Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.404 USD | +0.32% |
|
+4.81% | -47.98% |
Jun. 30 | Enlivex Therapeutics Ltd.'s Equity Buyback announced on August 30, 2023 has expired. | CI |
Jun. 24 | Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Bearish |
Resistance | 1.500 | 2.380 | 2.350 |
Spread/Res. | -8.00% | -42.02% | -41.28% |
Spread/Supp. | +8.66% | +8.66% | +4.55% |
Support | 1.270 | 1.270 | 1.320 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ENLV Stock
- Charts Enlivex Therapeutics Ltd.